{"id":162335,"date":"2023-11-15T18:52:00","date_gmt":"2023-11-15T18:52:00","guid":{"rendered":"https:\/\/v2.optiknow.ca\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/"},"modified":"2023-11-15T18:52:00","modified_gmt":"2023-11-15T18:52:00","slug":"lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd","status":"publish","type":"post","link":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/","title":{"rendered":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD"},"content":{"rendered":"\n<p>Le D<sup>r<\/sup> Sachdev Sidhu (chercheur \u00e0 l'Universit\u00e9 de Waterloo), financ\u00e9 par Vaincre la c\u00e9cit\u00e9 Canada, a mis au point un nouveau traitement par anticorps qui sera test\u00e9 lors d'un essai clinique de phase 1\/2 chez l'humain.<\/p>\n\n\n\n<p>Une barri\u00e8re h\u00e9mato-r\u00e9tinienne intacte est importante pour le bon fonctionnement de la r\u00e9tine. Dans certaines maladies oculaires, telles que la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l'\u00e2ge de forme humide (DMLA humide) et l'\u009cd\u00e8me maculaire diab\u00e9tique (OMD), cette barri\u00e8re est alt\u00e9r\u00e9e par la croissance incontr\u00f4l\u00e9e des vaisseaux sanguins, permettant au liquide de s'\u00e9couler dans l'\u009cil. Si ce probl\u00e8me n'est pas trait\u00e9, il pourrait entra\u00eener des l\u00e9sions r\u00e9tiennes et une perte de vision.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.optiknow.ca\/wp-content\/uploads\/2023\/11\/DR.-SIDHU.png\" alt=\"\" class=\"wp-image-103082\" style=\"aspect-ratio:1;width:269px;height:auto\"\/><figcaption class=\"wp-element-caption\">LES RECHERCHES DU DR. SIDHU<\/figcaption><\/figure>\n\n\n\n<p>Pr\u00e9sentement, le principal traitement pour la DMLA et l'OMD sont les m\u00e9dicaments anti-VEGF, qui r\u00e9duisent la croissance des vaisseaux sanguins. Cependant, les anti-VEGF ne r\u00e9parent pas les dommages caus\u00e9s \u00e0 la barri\u00e8re h\u00e9mato-r\u00e9tinienne.<\/p>\n\n\n\n<p>Le D<sup>r<\/sup> Sidhu a mis au point un nouveau traitement par anticorps (EYE103) ayant le potentiel de restaurer la barri\u00e8re h\u00e9mato-r\u00e9tinienne et d'aider \u00e0 am\u00e9liorer la vision chez les personnes atteintes de DMLA ou d'OMD.<\/p>\n\n\n\n<p>L'essai clinique sera men\u00e9 aupr\u00e8s de 90 patients (environ) et permettra de tester l'innocuit\u00e9 du traitement EYE103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Dr Sachdev Sidhu (chercheur \u00e0 l\u0092Universit\u00e9 de Waterloo), financ\u00e9 par Vaincre la c\u00e9cit\u00e9 Canada, a mis au point un nouveau traitement par anticorps qui sera test\u00e9 lors d\u0092un essai clinique de phase 1\/2 chez l\u0092humain.<\/p>\n","protected":false},"author":1,"featured_media":148583,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_angie_page":false,"page_builder":"","footnotes":""},"categories":[23144,23134],"tags":[],"class_list":["post-162335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communique-de-presse","category-science"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow\" \/>\n<meta property=\"og:description\" content=\"Le Dr Sachdev Sidhu (chercheur \u00e0 l\u0092Universit\u00e9 de Waterloo), financ\u00e9 par Vaincre la c\u00e9cit\u00e9 Canada, a mis au point un nouveau traitement par anticorps qui sera test\u00e9 lors d\u0092un essai clinique de phase 1\/2 chez l\u0092humain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/\" \/>\n<meta property=\"og:site_name\" content=\"OptikNow\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-15T18:52:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"810\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Optiknow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Optiknow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/\"},\"author\":{\"name\":\"Optiknow\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/person\\\/94d0fced8e14590d08b3c02ab7a8c150\"},\"headline\":\"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD\",\"datePublished\":\"2023-11-15T18:52:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/\"},\"wordCount\":253,\"publisher\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Research_FBC-Optik-logos-810x338-v2-1.jpg\",\"articleSection\":[\"Communiqu\u00e9 de presse\",\"Science\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/\",\"name\":\"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Research_FBC-Optik-logos-810x338-v2-1.jpg\",\"datePublished\":\"2023-11-15T18:52:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Research_FBC-Optik-logos-810x338-v2-1.jpg\",\"contentUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Research_FBC-Optik-logos-810x338-v2-1.jpg\",\"width\":810,\"height\":338,\"caption\":\"Fighting Blindness Canada\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2023\\\/11\\\/15\\\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\",\"name\":\"OptikNow\",\"description\":\"Canadian Eye Care and Eyewear News for Eye Care Professionals\",\"publisher\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\",\"name\":\"OptikNow\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cropped-Optik-NOW_RGB.png\",\"contentUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cropped-Optik-NOW_RGB.png\",\"width\":1181,\"height\":250,\"caption\":\"OptikNow\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/person\\\/94d0fced8e14590d08b3c02ab7a8c150\",\"name\":\"Optiknow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"caption\":\"Optiknow\"},\"sameAs\":[\"https:\\\/\\\/v2.optiknow.ca\"],\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/author\\\/optiknow\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow","og_description":"Le Dr Sachdev Sidhu (chercheur \u00e0 l\u0092Universit\u00e9 de Waterloo), financ\u00e9 par Vaincre la c\u00e9cit\u00e9 Canada, a mis au point un nouveau traitement par anticorps qui sera test\u00e9 lors d\u0092un essai clinique de phase 1\/2 chez l\u0092humain.","og_url":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/","og_site_name":"OptikNow","article_published_time":"2023-11-15T18:52:00+00:00","og_image":[{"width":810,"height":338,"url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg","type":"image\/jpeg"}],"author":"Optiknow","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Optiknow","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#article","isPartOf":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/"},"author":{"name":"Optiknow","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/person\/94d0fced8e14590d08b3c02ab7a8c150"},"headline":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD","datePublished":"2023-11-15T18:52:00+00:00","mainEntityOfPage":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/"},"wordCount":253,"publisher":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#organization"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#primaryimage"},"thumbnailUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg","articleSection":["Communiqu\u00e9 de presse","Science"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/","url":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/","name":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD - OptikNow","isPartOf":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#primaryimage"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#primaryimage"},"thumbnailUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg","datePublished":"2023-11-15T18:52:00+00:00","breadcrumb":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#primaryimage","url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg","contentUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Research_FBC-Optik-logos-810x338-v2-1.jpg","width":810,"height":338,"caption":"Fighting Blindness Canada"},{"@type":"BreadcrumbList","@id":"https:\/\/v2.optiknow.ca\/fr\/2023\/11\/15\/lancement-dun-essai-clinique-pour-tester-un-nouveau-medicament-contre-la-dmla-et-lomd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/v2.optiknow.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Lancement d\u0092un essai clinique pour tester un nouveau m\u00e9dicament contre la DMLA et l\u0092OMD"}]},{"@type":"WebSite","@id":"https:\/\/v2.optiknow.ca\/fr\/#website","url":"https:\/\/v2.optiknow.ca\/fr\/","name":"OptikNow","description":"Canadian Eye Care and Eyewear News for Eye Care Professionals","publisher":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/v2.optiknow.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/v2.optiknow.ca\/fr\/#organization","name":"OptikNow","url":"https:\/\/v2.optiknow.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/cropped-Optik-NOW_RGB.png","contentUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/cropped-Optik-NOW_RGB.png","width":1181,"height":250,"caption":"OptikNow"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/person\/94d0fced8e14590d08b3c02ab7a8c150","name":"Optiknow","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","caption":"Optiknow"},"sameAs":["https:\/\/v2.optiknow.ca"],"url":"https:\/\/v2.optiknow.ca\/fr\/author\/optiknow\/"}]}},"_links":{"self":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts\/162335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/comments?post=162335"}],"version-history":[{"count":0,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts\/162335\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/media\/148583"}],"wp:attachment":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/media?parent=162335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/categories?post=162335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/tags?post=162335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}